| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.66T | 7.24T | 6.76T | 6.57T | 6.22T | 5.63T |
| Gross Profit | 3.95T | 3.75T | 3.54T | 3.33T | 3.27T | 2.87T |
| EBITDA | 5.16T | 1.60T | 1.47T | 980.26B | 365.37B | 1.45T |
| Net Income | 3.68T | 1.15T | -227.65B | -970.14B | -1.71T | 4.99T |
Balance Sheet | ||||||
| Total Assets | 55.56T | 45.01T | 46.72T | 43.94T | 47.54T | 45.75T |
| Cash, Cash Equivalents and Short-Term Investments | 6.65T | 3.71T | 6.19T | 6.93T | 5.33T | 5.32T |
| Total Debt | 25.21T | 18.91T | 16.19T | 16.05T | 17.79T | 16.46T |
| Total Liabilities | 37.44T | 31.06T | 33.49T | 33.29T | 35.84T | 33.79T |
| Stockholders Equity | 15.45T | 11.56T | 11.16T | 9.03T | 9.98T | 10.21T |
Cash Flow | ||||||
| Free Cash Flow | -2.10T | 118.98B | -372.06B | 107.53B | 1.89T | -89.64B |
| Operating Cash Flow | -773.41B | 973.15B | 250.55B | 741.29B | 2.73T | 557.25B |
| Investing Cash Flow | -5.56T | -1.71T | -841.46B | 547.58B | -3.02T | -1.47T |
| Financing Cash Flow | 5.70T | -1.81T | -606.22B | 191.52B | 602.22B | 2.19T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥10.10T | 15.13 | 13.75% | 2.85% | 3.34% | 20.36% | |
66 Neutral | ¥23.34T | 6.36 | 24.50% | 0.25% | 7.31% | 44.73% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥410.56B | 17.99 | 15.67% | 1.31% | 12.48% | 18.38% | |
60 Neutral | ¥10.18T | 18.01 | ― | 3.99% | 7.79% | 5.53% | |
56 Neutral | ¥312.57B | 19.02 | 17.97% | 1.36% | 4.75% | 17.02% | |
56 Neutral | ¥13.07T | 11.76 | 10.59% | 3.36% | 2.10% | -9.29% |